Volume-2 ,Issue-8, August- 2026

3D printing, also known as additive manufacturing, has revolutionized the pharmaceutical industry by enabling the fabrication of personalized, complex, and patient-centric drug delivery systems. This review highlights the evolution, principles, and applications of 3D printing in pharmaceuticals, including tailored dosage forms, polypills, controlled-release systems, implants, and bioprinted tissues. The technology offers advantages such as customization, rapid prototyping, cost efficiency, and enhanced patient compliance, while challenges remain in the areas of material limitations, print accuracy, regulatory frameworks, scalability, and ethical considerations. Emerging trends, including integration with artificial intelligence, digital health, and bioprinting, promise to further expand its impact on precision medicine and advanced therapies. Addressing these challenges through standardization, quality control, and evidence-based regulatory guidelines will be critical for widespread adoption. Overall, 3D printing represents a state-of-the-art approach poised to transform pharmaceutical manufacturing and patient care.

Keyword: 3D printing, additive manufacturing, pharmaceuticals, personalized medicine, drug delivery